Cronos Group Inc. (CRON) Stock
1 member of Congress disclosed 2 trades in CRON since 2020: 2 purchases and 0 sales, most recently John A. Yarmuth (purchase, Feb 12, 2021). 4 of the hedge funds AlphaScala tracks reported CRON in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $24.55M.
Which members of Congress traded Cronos Group Inc. (CRON)?
Most recent: John A. Yarmuth (purchase, Feb 12, 2021); records start Nov 5, 2020.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| John Yarmuth D-KY · House | 2021-02-12 | purchase | $1k – $15k |
| John Yarmuth D-KY · House | 2020-11-05 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all CRON political trades →Which hedge funds own CRON?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 8.84M | $24.55M | +16% |
| Renaissance Technologies Jim Simons (founder) | 1.74M | $4.84M | -13% |
| Citadel Ken Griffin | 951K | $2.64M | +161% |
| Millennium Management Israel Englander | 96K | $266.7K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →CRON price chart
Powered by TradingViewWhat does Cronos Group Inc. do?
Cronos Group Inc. is a global cannabinoid company focused on building iconic brands and advancing research, technology, and product development in medical and adult-use cannabis markets. It operates primarily in Canada, Israel, and international regions including Europe, offering a diverse portfolio of premium cannabis products such as flower, pre-rolls, vapes, gummies, and extracts. Key brands include Spinach® for innovative edibles and vapes like PUFFERZ™, SOURZ®, and seasonal flavors; Lord Jones® for high-potency live resin fusions and indoor-grown flower; and PEACE NATURALS® for medical cannabis distribution. The company leverages cultivation through Cronos GrowCo, emphasizing small-batch production, liquid diamonds infusion, and terpene-rich formulations to meet consumer demand for quality, convenience, and potency. Cronos Group Inc. pursues strategic international partnerships and transactions, such as expanding into Switzerland and the Netherlands' adult-use pilot program, positioning it as a key player in the evolving global cannabis industry. Founded in 2018 and headquartered in Toronto, Canada, it supports borderless product strategies across recreational and medicinal segments.